Sharmila Manian/LinkedIn
Apr 1, 2026, 11:53
Sharmila Manian: The Mystery of the Positive Direct Coombs Test in Donors
Sharmila Manian, Transfusion Medicine Specialist at Hospital Sultan Ismail, shared a post on LinkedIn:
“The Mystery of the Positive Direct Coombs Test (DCT) in Donors
Why does a perfectly healthy blood donor sometimes test positive on a Direct Coombs Test (DCT)?
It’s a common lab puzzle with a simple explanation.
The ‘Why’: Why do healthy donors test positive?
- Biological Variants: Some people naturally carry low-level autoantibodies that cause them zero harm.
- Medication Spikes: Common drugs (like certain antibiotics) can make the immune system ‘stick’ to red cells.
- Post-Viral Echo: A recent minor cold can leave behind elevated proteins (globulins) that the test picks up.
The ‘Why Not’: Why do we prevent these transfusions?
Even if the donor feels 100% fine, we pull these units from the supply to:
- Avoid Lab Delays: These units often show up as ‘incompatible’ during crossmatching, slowing down urgent care.
- Protect the Recipient: We aim to eliminate any risk of febrile or hemolytic reactions in the patient.
- Maintain Gold Standards: To ensure the highest purity and safety of every bag of blood.
Bottom Line: A positive DCT in a donor is usually a biological quirk, not a medical emergency.
However, for the blood bank, it’s a signal to divert that unit toward research instead of the bedside.”

Stay updated with Hemostasis Today.
-
Sep 3, 2026, 11:21Thrombotic Microangiopathies: From Clinical Syndrome to Molecularly Targeted Therapy
-
Sep 3, 2026, 10:56Elias Othman: Can an Enzyme Involved in Cell Signaling Become a Target for Antithrombotic Drug Discovery?
-
Sep 3, 2026, 10:42Jared Griffard: Hemorrhagic Shock and Component Blood Transfusion
-
Sep 3, 2026, 10:31Alan Nurden: Comparing Antiplatelet and Antithrombin Therapies in Coronary Microcirculation
-
Sep 3, 2026, 08:53Jamie’s Journey Through a Decade with Immune Thrombocytopenia – ITP Support Association
-
Sep 3, 2026, 08:00Beth Meneley: When Transfusion Is Not an Option – HBOT for Exceptional Blood Loss Anemia
-
Sep 3, 2026, 06:27Seyed Mehrab Safdari: Unmasking Factor VII Padua to Prevent Unnecessary Therapy and Thrombotic Risk
-
Sep 3, 2026, 04:09Pedro Perez: Are We Entering a New Era in the Treatment of Intermediate-High-Risk PE?
-
Sep 3, 2026, 04:01Marianne Yee: Supporting Families and Transformative Therapies in Sickle Cell Disease